Parisa Momtaz

3PUBLICATIONS
30CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 13, 2026
Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma.

|May 20, 2024
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study.

James W Smithy, Hannah L Kalvin, Fiona D Ehrich

|Aug 05, 2021
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes.

Parisa Momtaz, Catherine A O'Connor, Joanne F Chou

Pageof 1